CLINICAL STUDY: INTERVENTIONAL CARDIOLOGY
Coronary artery stenting in the aged
Manish S. Chauhan, MD*  ,
Richard E. Kuntz, MD, MSc ,
Kalon K. L. Ho, MD, MSc, FACC* ,
David J. Cohen, MD, MSc*,
Jeffrey J. Popma, MD, FACC,
Joseph P. Carrozza, Jr, MD, FACC*,
Donald S. Baim, MD, FACC and
Donald E. Cutlip, MD, FACC
* Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
Brigham and Women’s Hospital, Boston, Massachusetts, USA
Harvard Clinical Research Institute and Cardiovascular Data Analysis Center, Boston, Massachusetts, USA
Manuscript received April 12, 2000;
revised manuscript received October 16, 2000,
accepted November 17, 2000.
Reprint requests and correspondence: Dr. Manish S. Chauhan, Interventional Cardiology Section, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, Massachusetts 02215
mchauhan{at}caregroup.harvard.edu
OBJECTIVES
The study compared the safety and efficacy of coronary artery stenting in aged and nonaged patients and identified predictors of adverse clinical outcomes.
BACKGROUND
Limited data are available on the outcomes of stenting in the aged ( 80 years) compared to nonaged patients.
METHODS
The study was a pooled analysis of 6,186 patients who underwent coronary artery stenting in six recent multicenter trials. A clinical events committee adjudicated clinical end points, and quantitative angiography was performed by an independent core laboratory.
RESULTS
There were 301 (4.9%) aged patients (80 years). Compared to nonaged patients, aged patients had a higher prevalence of multivessel disease (16.5% vs. 9.6%, p = 0.001), unstable angina (50.8% vs. 42.1%, p = 0.003), moderate to severe target lesion calcification (30.4% vs. 15.3%, p = 0.001) and smaller reference vessel diameter (2.90 mm vs. 2.98 mm, p = 0.004). Procedural success rate (97.4% vs. 98.5%, p = 0.14) was similar in the two groups. In-hospital mortality (1.33% vs. 0.10%, p = 0.001), bleeding complications (4.98% vs. 1.00%, p < 0.001) and one-year mortality (5.65% vs. 1.41%, p < 0.001) were significantly higher for the aged patients. Clinical restenosis was similar for the two groups (11.19% vs. 11.93%, p = 0.78). Advanced age, diabetes, prior myocardial infarction and presence of three-vessel disease were independent predictors of long-term mortality.
CONCLUSIONS
Coronary artery stenting can be performed safely in patients 80 years of age, with excellent acute results and a low rate of clinical restenosis, albeit with higher incidences of in-hospital and long-term mortality, and vascular and bleeding complications compared to nonaged patients.
|
Abbreviations and Acronyms
| | CABG | = coronary artery bypass graft | | EPISTENT | = Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial | | Gp | = glycoprotein | | MI | = myocardial infarction | | PCI | = percutaneous coronary intervention | | QCA | = quantitative coronary angiography | | QMI | = Q-wave myocardial infarction | | STARS | = Stent Antithrombotic Regimen Study | | TLR | = target lesion revascularization | | TVR | = target vessel revascularization |
|
This article has been cited by other articles:
|
|
|
|
 
H. V. Anderson
Drug-Eluting Stents: Life Insurance With a Better Death Benefit
J. Am. Coll. Cardiol.,
May 27, 2008;
51(21):
2025 - 2027.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. G. P. Roberts, E. Guallar, and A. Rodriguez
Efficacy and Safety of Statin Monotherapy in Older Adults: A Meta-Analysis
J. Gerontol. A Biol. Sci. Med. Sci.,
August 1, 2007;
62(8):
879 - 887.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. Williams
Coronary Revascularization in Diabetic Chronic Kidney Disease/End-Stage Renal Disease: A Nephrologist's Perspective
Clin. J. Am. Soc. Nephrol.,
March 1, 2006;
1(2):
209 - 220.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Torella, D. Leosco, C. Indolfi, A. Curcio, C. Coppola, G. M. Ellison, V. G. Russo, M. Torella, G. L. Volti, F. Rengo, et al.
Aging exacerbates negative remodeling and impairs endothelial regeneration after balloon injury
Am J Physiol Heart Circ Physiol,
December 1, 2004;
287(6):
H2850 - H2860.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Gilbert, J. Raboud, and B. Zinman
Meta-Analysis of the Effect of Diabetes on Restenosis Rates Among Patients Receiving Coronary Angioplasty Stenting
Diabetes Care,
April 1, 2004;
27(4):
990 - 994.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J D Ferguson, W P Orr, C J McKenna, D J Blackman, K M Channon, J C Forfar, O Ormerod, and A P Banning
Percutaneous coronary intervention in octogenarians with refractory angina
Heart,
July 1, 2002;
88(1):
85 - 86.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Tariq, R. Carroll, I. Zabih, R.G. Stenberg, and K.M.A. Hussain
Emergency Coronary Stenting for Complete Thrombotic Occlusion of an Unprotected Left Main Coronary Artery in Acute Myocardial Infarction Complicated by Cardiogenic Shock in an Octogenarian Patient: A Case Report
Angiology,
January 1, 2002;
53(1):
95 - 98.
[Abstract]
[PDF]
|
|
|
|
